Literature DB >> 31216426

Inhibition of FPR2 impaired leukocytes recruitment and elicited non-resolving inflammation in acute heart failure.

Vasundhara Kain1, Jeevan Kumar Jadapalli1, Bochra Tourki1, Ganesh V Halade2.   

Abstract

Lifestyle or age-related risk factors over-activate the inflammation that triggers acute heart failure (HF)-related mortality following myocardial infarction (MI). Post-MI activated leukocytes express formyl peptide receptor 2 (FPR2) that is essential for inflammation-resolution and in cardiac healing. However, the role of FPR2 in acute HF is incomplete and remain of interest. Here, we aimed to determine whether pharmacological inhibition of FPR2 perturb leukocyte trafficking in acute HF. Male C57BL/6 (8-12 weeks) mice were subjected to acute HF (MI-d1) using permanent coronary artery ligation that develops irreversible acute and chronic heart failure. FPR2 antagonist WRW4 (1 μg/kg/day) was subcutaneously injected 3 h post-MI maintaining saline-injected MI-controls. Leukocytes were quantitated using flow cytometry, and acute decompensated HF was confirmed using echocardiography and histology. FPR2 inhibition decreased the expression of FPR2 in the LV and spleen tissues. Administration of WRW4 inhibitor to mice primed immature and inactive neutrophils infiltration Ly6Gint and intensified the Ccl2 expression compared to MI-control in the infarcted LV post-MI. Leukocyte profiling revealed an overall decrease in monocytes (23.3 ± 2%) in WRW4-injected mice compared with MI-control (49.1 ± 2%) in infarcted LV. FPR2 inhibition increased F4/80+/Ly6Chi pro-inflammatory macrophages (14.8 ± 2%) compared with MI-control (10 ± 1%) with increased transcripts of pro-inflammatory markers TNF-α and IL-1β, and decreased Arg-1 expression in the infarcted LV compared to MI-controls is suggestive of the impaired acute inflammatory response. Inhibition of FPR2 using WRW4 also disturbed splenocardiac leukocytes recruitment by priming immature neutrophils leading to the onset of incomplete resolution signaling in acute decompensated HF post-MI. Published by Elsevier Ltd.

Entities:  

Keywords:  Formyl peptide receptor; Inflammation; Leukocytes; Myocardial infarction; Resolution of inflammation

Year:  2019        PMID: 31216426      PMCID: PMC6679729          DOI: 10.1016/j.phrs.2019.104295

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  35 in total

1.  Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.

Authors:  Vasundhara Kain; Kevin A Ingle; Romain A Colas; Jesmond Dalli; Sumanth D Prabhu; Charles N Serhan; Medha Joshi; Ganesh V Halade
Journal:  J Mol Cell Cardiol       Date:  2015-04-11       Impact factor: 5.000

Review 2.  The chemokine system in innate immunity.

Authors:  Caroline L Sokol; Andrew D Luster
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-29       Impact factor: 10.005

3.  Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.

Authors:  Shantel A Vital; Felix Becker; Paul M Holloway; Janice Russell; Mauro Perretti; D Neil Granger; Felicity N E Gavins
Journal:  Circulation       Date:  2016-05-06       Impact factor: 29.690

4.  Splenic leukocytes define the resolution of inflammation in heart failure.

Authors:  Ganesh V Halade; Paul C Norris; Vasundhara Kain; Charles N Serhan; Kevin A Ingle
Journal:  Sci Signal       Date:  2018-03-06       Impact factor: 8.192

Review 5.  Regulation of the inflammatory response in cardiac repair.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2012-01-06       Impact factor: 17.367

Review 6.  FPR2: A Novel Promising Target for the Treatment of Influenza.

Authors:  Marie-Christine Alessi; Nicolas Cenac; Mustapha Si-Tahar; Béatrice Riteau
Journal:  Front Microbiol       Date:  2017-09-05       Impact factor: 5.640

7.  Guidelines for experimental models of myocardial ischemia and infarction.

Authors:  Merry L Lindsey; Roberto Bolli; John M Canty; Xiao-Jun Du; Nikolaos G Frangogiannis; Stefan Frantz; Robert G Gourdie; Jeffrey W Holmes; Steven P Jones; Robert A Kloner; David J Lefer; Ronglih Liao; Elizabeth Murphy; Peipei Ping; Karin Przyklenk; Fabio A Recchia; Lisa Schwartz Longacre; Crystal M Ripplinger; Jennifer E Van Eyk; Gerd Heusch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-12       Impact factor: 4.733

8.  Acute Heart Failure developed as worsening of Chronic Heart Failure is associated with increased mortality compared to de novo cases.

Authors:  Vesna Degoricija; Matias Trbušić; Ines Potočnjak; Bojana Radulović; Sanda Dokoza Terešak; Gudrun Pregartner; Andrea Berghold; Beate Tiran; Saša Frank
Journal:  Sci Rep       Date:  2018-06-25       Impact factor: 4.379

Review 9.  The downstream regulation of chemokine receptor signalling: implications for atherosclerosis.

Authors:  Jyoti Patel; Keith M Channon; Eileen McNeill
Journal:  Mediators Inflamm       Date:  2013-04-14       Impact factor: 4.711

10.  Resolution Agonist 15-epi-Lipoxin A4 Programs Early Activation of Resolving Phase in Post-Myocardial Infarction Healing.

Authors:  Vasundhara Kain; Fei Liu; Veronika Kozlovskaya; Kevin A Ingle; Subhashini Bolisetty; Anupam Agarwal; Santosh Khedkar; Sumanth D Prabhu; Eugenia Kharlampieva; Ganesh V Halade
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

View more
  10 in total

1.  Deficit of resolution receptor magnifies inflammatory leukocyte directed cardiorenal and endothelial dysfunction with signs of cardiomyopathy of obesity.

Authors:  Bochra Tourki; Vasundhara Kain; Saame Raza Shaikh; Xavier Leroy; Charles N Serhan; Ganesh V Halade
Journal:  FASEB J       Date:  2020-06-16       Impact factor: 5.191

Review 2.  Role of neutrophils in ischemic heart failure.

Authors:  Vasundhara Kain; Ganesh V Halade
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

3.  Identification and analysis of key genes associated with acute myocardial infarction by integrated bioinformatics methods.

Authors:  Siyu Guo; Jiarui Wu; Wei Zhou; Xinkui Liu; Yingying Liu; Jingyuan Zhang; Shanshan Jia; Jialin Li; Haojia Wang
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

4.  Reversal of β-Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3.

Authors:  Edward S Wickstead; Husnain A Karim; Roberta E Manuel; Christopher S Biggs; Stephen J Getting; Simon McArthur
Journal:  Oxid Med Cell Longev       Date:  2020-06-13       Impact factor: 6.543

5.  Potential Target Genes in the Development of Atrial Fibrillation: A Comprehensive Bioinformatics Analysis.

Authors:  Liang Liu; Yun Yu; Long-Long Hu; Quan-Bin Dong; Feng Hu; Ling-Juan Zhu; Qian Liang; Ling-Ling Yu; Hui-Hui Bao; Xiao-Shu Cheng
Journal:  Med Sci Monit       Date:  2021-03-20

6.  Suppression of FPR2 expression inhibits inflammation in preeclampsia by improving the biological functions of trophoblast via NF-κB pathway.

Authors:  Shuxian Li; Anna Li; Liping Zhai; Yaqiong Sun; Ling Yu; Zhenya Fang; Lin Zhang; Yanjie Peng; Meihua Zhang; Xietong Wang
Journal:  J Assist Reprod Genet       Date:  2022-01-11       Impact factor: 3.412

Review 7.  Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35.

Authors:  Cheng Xue Qin; Lucy V Norling; Elizabeth A Vecchio; Eoin P Brennan; Lauren T May; Denise Wootten; Catherine Godson; Mauro Perretti; Rebecca H Ritchie
Journal:  Br J Pharmacol       Date:  2022-07-29       Impact factor: 9.473

Review 8.  Possible protective effect of resolvin D1 on inflammation in atrial fibrillation: involvement of ER stress mediated the NLRP3 inflammasome pathway.

Authors:  Fatemeh Yarmohammadi; A Wallace Hayes; Gholamreza Karimi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-03       Impact factor: 3.000

Review 9.  Regulation of Inflammation and Oxidative Stress by Formyl Peptide Receptors in Cardiovascular Disease Progression.

Authors:  Valentina Maria Caso; Valentina Manzo; Tiziana Pecchillo Cimmino; Valeria Conti; Pio Caso; Gabriella Esposito; Vincenzo Russo; Amelia Filippelli; Rosario Ammendola; Fabio Cattaneo
Journal:  Life (Basel)       Date:  2021-03-15

Review 10.  Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.

Authors:  Juan Salazar; Daniela Pirela; Manuel Nava; Ana Castro; Lissé Angarita; Heliana Parra; Samuel Durán-Agüero; Diana Marcela Rojas-Gómez; Néstor Galbán; Roberto Añez; Maricarmen Chacín; Andrea Diaz; Nelson Villasmil; Juan Bautista De Sanctis; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.